Eco R1 Capital, LLC Igm Biosciences, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $3.96 Million - $7.61 Million	-298,597 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $4.01 Million - $8.88 Million	298,597 New	298,597 $7.98 Million
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $1.05 Million - $2.52 Million	-38,030 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $2.2 Million - $3.67 Million	38,030 New	38,030 $3.16 Million
Q1 2020 May 15, 2020	SELL	$31.51 - $73.75 $3.15 Million - $7.38 Million	-100,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $1.78 Million - $2.43 Million	100,000 New	100,000 $1.78 Million

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.